Graves' Hyperthyroidism Following Transient Thyrotoxicosis during Interferon Therapy for Chronic Hepatitis Type C

We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456×106 units of IFN-α for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis....

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine Vol. 34; no. 1; pp. 58 - 60
Main Authors: KOIZUMI, Shigeki, MASHIO, Yasuo, MIZUO, Hitoshi, MATSUDA, Akira, MATSUYA, Kumiko, MIZUMOTO, Hiroaki, IKOTA, Akemi, BENIKO, Mutsuo, IRIUDA, Yoshiyori
Format: Journal Article
Language:English
Published: Tokyo The Japanese Society of Internal Medicine 1995
Japanese Society of Internal Medicine
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456×106 units of IFN-α for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis. One week after the termination of IFN therapy, TSH-receptor antibodies became positive and subsequently she showed Graves' hyperthyroidism. This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy. The course of this case may be useful in the understanding of the pathogenesis of autoimmune hyperthyroidism. (Internal Medicine 34: 58-60, 1995)
AbstractList We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy. A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456 x 10(6) units of IFN-alpha for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis. One week after the termination of IFN therapy, TSH-receptor antibodies became positive and subsequently she showed Graves' hyperthyroidism. This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy. The course of this case may be useful in the understanding of the pathogenesis of autoimmune hyperthyroidism.
We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456×106 units of IFN-α for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis. One week after the termination of IFN therapy, TSH-receptor antibodies became positive and subsequently she showed Graves' hyperthyroidism. This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy. The course of this case may be useful in the understanding of the pathogenesis of autoimmune hyperthyroidism. (Internal Medicine 34: 58-60, 1995)
Author MIZUO, Hitoshi
MATSUYA, Kumiko
MASHIO, Yasuo
MATSUDA, Akira
IRIUDA, Yoshiyori
KOIZUMI, Shigeki
BENIKO, Mutsuo
MIZUMOTO, Hiroaki
IKOTA, Akemi
Author_xml – sequence: 1
  fullname: KOIZUMI, Shigeki
  organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital
– sequence: 2
  fullname: MASHIO, Yasuo
  organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital
– sequence: 3
  fullname: MIZUO, Hitoshi
  organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital
– sequence: 4
  fullname: MATSUDA, Akira
  organization: Kin-ikyo Chuo Hospital
– sequence: 5
  fullname: MATSUYA, Kumiko
  organization: Kin-ikyo Chuo Hospital
– sequence: 6
  fullname: MIZUMOTO, Hiroaki
  organization: Kin-ikyo Chuo Hospital
– sequence: 7
  fullname: IKOTA, Akemi
  organization: Kin-ikyo Chuo Hospital
– sequence: 8
  fullname: BENIKO, Mutsuo
  organization: Kin-ikyo Chuo Hospital
– sequence: 9
  fullname: IRIUDA, Yoshiyori
  organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3476404$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7718983$$D View this record in MEDLINE/PubMed
BookMark eNplkMFuGyEQhlGVKHXSPkIiDpV6Wgd2dpflWFlNHClSLu55RWCIidawBdLWb19WtnxILoPE9w0z_JfkzAePhNxwtqx5J2-dzxi9GndonHYel9As2_4TWXBoZCVqaM_IgkneV3Upn8llSq-MQS9kfUEuhOC97GFBft9H9QfTd7reTxjzdh-DMy7t6F0Yx_DX-Re6iconhz7TzYxz-Od0SC5R8xZn_jBvYjEGXwSMatpTGyJdbcuN03SNk8ouF39TRtDVF3Ju1Zjw6_G8Ir_ufm5W6-rx6f5h9eOx0q3oc8U17xoFUFvA2mopawYSNKAyouk6IxRoZpQxgPDc9h3jyljgUthaMskQrkh3eFfHkFJEO0zR7VTcD5wNc4TD-wgHaIa2L43Xh8bp7bmgU9sxs8K_HblKWo22xKNdOmnQiK5hTdGeDtpryuoFT1zF7PSIH6bz8sV5A34obX8y9VbFAT38B9tfoNY
CitedBy_id crossref_primary_10_1515_JPEM_2007_20_2_237
crossref_primary_10_2957_kanzo_51_300
crossref_primary_10_1097_01_rlu_0000170014_35693_6c
crossref_primary_10_1507_endocrj_52_293
crossref_primary_10_1007_BF03259299
crossref_primary_10_1089_107999099314450
crossref_primary_10_3346_jkms_2011_26_12_1638
ContentType Journal Article
Copyright The Japanese Society of Internal Medicine
1995 INIST-CNRS
Copyright_xml – notice: The Japanese Society of Internal Medicine
– notice: 1995 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.2169/internalmedicine.34.58
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-7235
EndPage 60
ExternalDocumentID 10_2169_internalmedicine_34_58
7718983
3476404
article_internalmedicine1992_34_1_34_1_58_article_char_en
Genre Journal Article
Case Reports
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
7.U
AAPBV
AAUGY
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
EBS
EJD
EMOBN
F5P
HYE
JSF
JSH
M48
M~E
OK1
P2P
RJT
RNS
RPM
RZJ
TKC
TR2
X7M
XSB
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PGMZT
AAYXX
CITATION
ID FETCH-LOGICAL-c578t-1c164a332f3e2fc9920393c3ead7466d7a3c0dadd3e3b58601adf3197f29090e3
ISSN 0918-2918
IngestDate Fri Aug 23 04:02:17 EDT 2024
Sat Sep 28 08:36:47 EDT 2024
Sun Oct 29 17:10:34 EDT 2023
Thu Aug 17 20:27:31 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Endocrinopathy
Human
Toxicity
Hyperthyroidism
Thyroid diseases
Autoimmune disease
Transitory
Case study
Immunomodulator
Chemotherapy
Graves disease
Antiviral
Female
Interferon
Long lasting
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c578t-1c164a332f3e2fc9920393c3ead7466d7a3c0dadd3e3b58601adf3197f29090e3
OpenAccessLink https://www.jstage.jst.go.jp/article/internalmedicine1992/34/1/34_1_58/_article/-char/en
PMID 7718983
PageCount 3
ParticipantIDs crossref_primary_10_2169_internalmedicine_34_58
pubmed_primary_7718983
pascalfrancis_primary_3476404
jstage_primary_article_internalmedicine1992_34_1_34_1_58_article_char_en
PublicationCentury 1900
PublicationDate 1995
1995-Jan
1995-00-00
PublicationDateYYYYMMDD 1995-01-01
PublicationDate_xml – year: 1995
  text: 1995
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Internal Medicine
PublicationTitleAlternate Intern. Med.
PublicationYear 1995
Publisher The Japanese Society of Internal Medicine
Japanese Society of Internal Medicine
Publisher_xml – name: The Japanese Society of Internal Medicine
– name: Japanese Society of Internal Medicine
References 4) Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterol 102: 2155, 1992.
7) Abe T, Suga M, Ono A, et al. A case of hyperthyroidism appeared during interferon treatment for chronic hepatitis C. Nippon Shokakibyo Gakkai Zasshi 90: 818, 1993 (in Japanese).
3) Burman P, Karlsson FA, Oberg K, Aim G. Autoimmune thyroid disease in interferon-treated patients. Lancet 100, 1985.
5) Papo T, Oksenhendler E, Izembart M, Leger A, Clauvel J-P. Antithyroid hormone antibodies induced by interferon-α. J Clin Endocrinol Metab 75: 1484, 1992.
10) Golub SH. Immunological and therapeutic effects of interferon treatment of cancer patients. Clin Immunol Allergy 4: 377, 1984.
14) Daniels HM, Meager A, Eddleston ALWF, et al. Spontaneous production of tumour necrosis factor a and interleukin-16 during interferon-α treatment of chronic HBV infection. Lancet 335: 875, 1990.
6) Taniguchi Y, Murakami T, Nakanishi K, et al. Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Medicine 31: 373, 1992.
1) Davis TF. New thinking on the immunology of Graves' disease. Thyroid Today 15: 1, 1992.
13) Mayet W-J, Hess G, Gerken G, et al. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10: 24, 1989.
8) Mashio Y, Beniko B, Ikota A, Mizumoto H, Kunita H. Treatment of hyperthyroidism with a small single daily dose of methimazole. Acta Endocrinologica (Copenh) 119: 139, 1988.
11) Hanafusa T, Pujol-Borrell R, Chiovato L, et al. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2: 1111, 1983.
12) Jansson R, Karlsson A, Forsum U. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol 58: 264,1984.
17) Wartofsky L. Graves' disease with thyrotoxicosis following subacute thyroiditis. Am J Med 83: 761, 1987.
16) Werner SC. Graves' disease following acute (subacute) thyroiditis. Arch Intern Med 139: 1313, 1979.
15) Sheets RF. The sequential occurrence of acute thyroiditis and thyrotoxicosis. JAMA 157: 139, 1955.
2) Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1166, 1985.
9) Kasagi K, Konishi J, Arai K, et al. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. J Clin Endocrinol Metab 62: 855, 1986.
References_xml
SSID ssj0038792
Score 1.5129777
Snippet We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and...
We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy. A 52-year-old woman suffered from chronic active hepatitis type C...
SourceID crossref
pubmed
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 58
SubjectTerms Autoantibodies - blood
autoimmunity
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Female
Graves Disease - chemically induced
Graves Disease - immunology
Hepatitis C - drug therapy
Hepatitis C - immunology
Hepatitis, Chronic - drug therapy
Hepatitis, Chronic - immunology
Humans
Interferon-alpha - adverse effects
Interferon-alpha - immunology
Medical sciences
Middle Aged
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Radioimmunoassay
Receptors, Thyrotropin - immunology
Thyrotoxicosis - complications
TSH-receptor antibody
Title Graves' Hyperthyroidism Following Transient Thyrotoxicosis during Interferon Therapy for Chronic Hepatitis Type C
URI https://www.jstage.jst.go.jp/article/internalmedicine1992/34/1/34_1_58/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/7718983
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Internal Medicine, 1995, Vol.34(1), pp.58-60
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6gRASQtwmCgz5AYkHlK2xndtjtXakmsYemkqIlygXm3WTmtGLtp_PObbjXsYDIHiJKseJnHxfzy0-5xDyIWRJWTIuvJLjZ8akVl5ZF4kXqVgFFSjEosCAWzqOvnyNB0Mx7HTaYp_rsf-KNIwB1pg5-wdou5vCAPwGzOEIqMPxt3D_jP2E9NaIFFzMOeAwb6Y1tsI4BcibWwwNaAWFiZCfMjy9bO6AD1iZxCYt6jChknNgRmaqDujdiLaQLqgq3Ia9hPnoxdo469V6S7y2cM93PtqfXYy-Tc5HOtp6Of0ur6cO6_44HV1oXVAsVo0bhvl6NAWhs7jcmJ6NJ4O-FmrX03mxjltgHrjjmM55A0sAO2y6vak2b-b-Am2w0sdcESuppRHVXAClmCl20spyGxjd5KwRzEG8oeJNB4Nd5cH8EGuvTu0y2r0NR1wctVdvFea2EOe7F-CG3pyL3DeHIM7bmZhIBxzdIw8YiEXstzEYnbV2A48j3cLbPavJZ8dVHf96TVum1MMr8CawTMSTm2IBf29l-rLseEvaasqekafW3aF9s7TnpCNnL8ij9tW_JD8MXT_SHbJSR1bqyEq3yUoNWemarNSSlQJZqSUrdWSlSFZ68opMTofZSerZLiBeBdpk6fkVePQF50xxyRSID4bp5BUHERiJMKyjgle9GtQ0l7wM4rDnF7UCxRIplvSSnuQHZH_WzORrQgMJ5rLwIxXGsfDLsqwEg0ukVFLImhVdcty-0PzGFHvJwUlGCO6hjOAGcZek5r27-X_Nii453ELO3ZGLKBQ90SUHBkl3IgK7Mon5m3-3hrfksSnZgCHGd2R_OV_JQ7K3qFfvNVd_AqJG6hc
link.rule.ids 315,782,786,4028,27932,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Graves%27+Hyperthyroidism+Following+Transient+Thyrotoxicosis+during+Interferon+Therapy+for+Chronic+Hepatitis+Type+C&rft.jtitle=Internal+Medicine&rft.au=KOIZUMI%2C+Shigeki&rft.au=MASHIO%2C+Yasuo&rft.au=MIZUO%2C+Hitoshi&rft.au=MATSUDA%2C+Akira&rft.date=1995&rft.pub=The+Japanese+Society+of+Internal+Medicine&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=34&rft.issue=1&rft.spage=58&rft.epage=60&rft_id=info:doi/10.2169%2Finternalmedicine.34.58&rft.externalDocID=article_internalmedicine1992_34_1_34_1_58_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon